Trump issues drug pricing ultimatum to biopharma CEOs

President Donald Trump Friday gave biopharma CEOs a choice: accept an international reference pricing scheme for biologics or propose an alternative that achieves the same goals.

The ultimatum was issued at a White House event where Trump signed four executive orders that he said would quickly lead to “massive reductions in drug costs.” It isn’t clear, however, when or whether they will go into effect. ...